
Last Posted: Apr 24, 2021
- Comparison of Survival After Breast-Conserving Therapy vs Mastectomy Among Patients With or Without the BRCA1/2 Variant in a Large Series of Unselected Chinese Patients With Breast Cancer
Q Wan et al, JAMA Network Open, April 23, 2021 - Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study.
Kim Joo Heung et al. Scientific reports 2021 11(1) 8485 - Prospective assessment of breast cancer risk from multimodal multiview ultrasound images via clinically applicable deep learning.
Qian Xuejun et al. Nature biomedical engineering 2021 - Outcomes of large panel genetic evaluation of breast cancer patients in a community-based cancer institute.
Bagwell Alexis K et al. American journal of surgery 2021 - Validation of breast cancer risk assessment tools on a French-Canadian population-based cohort.
Jantzen Rodolphe et al. BMJ open 2021 11(4) e045078 - Predicting breast cancer 5-year survival using machine learning: A systematic review.
Li Jiaxin et al. PloS one 2021 16(4) e0250370 - Controversies in Hereditary Cancer Management.
AlHilli Mariam M et al. Obstetrics and gynecology 2021 - HER2 testing in breast cancers: comparison of assays and interpretation using ASCO/CAP 2013 and 2018 guidelines.
McLemore Lauren E et al. Breast cancer research and treatment 2021 - Multigene assessment of genetic risk for women for two or more breast cancers.
Weitzel Jeffrey N et al. Breast cancer research and treatment 2021 - Comprehensive analysis of germline mutations in northern Brazil: a panel of 16 genes for hereditary cancer-predisposing syndrome investigation.
Vidal Amanda Ferreira et al. BMC cancer 2021 21(1) 363
More
Search Result Summary
- CDC Information (19)
- NIH Information (16)
- CDC Publications (10)
- COVID-19 (22)
- Human Genome Epidemiologic Studies (6946)
- GWAS Studies (104)
- Human Genomics Translation/Implementation Studies (1768)
- Genomic Tests Evidence Synthesis (158)
- Genomic Tests Guidelines (80)
- Tier-Classified Guidelines (34)
- Non-Genomics Precision Health (150)
- Pathogen Advanced Molecular Detection (2)
- State Public Health Genomics Programs (118)
- Ethical/Legal and Social Issues (ELSI) (29)
Quick Links to Other Resources
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2020
- Page last updated:Apr 26, 2021
- Content source:

